These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 20172938

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sevoflurane reduces leukocyte and platelet adhesion after ischemia-reperfusion by protecting the endothelial glycocalyx.
    Chappell D, Heindl B, Jacob M, Annecke T, Chen C, Rehm M, Conzen P, Becker BF.
    Anesthesiology; 2011 Sep; 115(3):483-91. PubMed ID: 21785339
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts.
    Beresewicz A, Czarnowska E, Maczewski M.
    Mol Cell Biochem; 1998 Sep; 186(1-2):87-97. PubMed ID: 9774189
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
    Li H, Wang JK, Zeng YM, Yang CX, Chen HT, Wen XJ, Shui CL, Liang H.
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of sevoflurane in hepatic ischemia-reperfusion injury.
    Li J, Yuan T, Zhao X, Lv GY, Liu HQ.
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):300-7. PubMed ID: 26966142
    [Abstract] [Full Text] [Related]

  • 10. The volatile anesthetic sevoflurane mitigates cardiodepressive effects of platelets in reperfused hearts.
    Heindl B, Conzen PF, Becker BF.
    Basic Res Cardiol; 1999 Apr; 94(2):102-11. PubMed ID: 10326658
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts.
    Novalija E, Fujita S, Kampine JP, Stowe DF.
    Anesthesiology; 1999 Sep; 91(3):701-12. PubMed ID: 10485782
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion.
    Chappell D, Dörfler N, Jacob M, Rehm M, Welsch U, Conzen P, Becker BF.
    Shock; 2010 Aug; 34(2):133-9. PubMed ID: 20634656
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts.
    Kaneda K, Miyamae M, Sugioka S, Okusa C, Inamura Y, Domae N, Kotani J, Figueredo VM.
    Anesth Analg; 2008 Jan; 106(1):9-16, table of contents. PubMed ID: 18165545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.